Very timely Yorky- wish DNAP would put out something similar...
"Merck is betting, however, that its partnership with Decode will help it more quickly determine which of its experimental drug compounds will alter the course of a disease... Decode has built up a unique database of DNA samples from the isolated Icelandic population, along with their medical histories and genealogy. Its technology is designed to assess how people respond to drugs based on their genetic makeup...
Instead, drugs will be measured against the specific genetic makeup of the individuals in the trial."
News 
Market Data 
Discover 
